Hi ,

SynBioBeta is just seven months away, and we're eagerly looking forward to it. This year, we'll be gathering at the San Jose Convention Center, conveniently located between the Marriott and the Hilton. If you're considering exhibiting for the first time in 2024 or looking for budgeting advice, reach out to Anissa Cooke (anissa.cooke@synbiobeta.com). She can provide details on a special discount for first-timers and assist with budgeting. Looking forward to seeing everyone!

Also, following the editorial published in Nature Biotechnology, “The community of the DAO,” ValleyDAO will be hosting a talk on 𝕏 with Ross Cloney and Barbara Cheifet of Springer-Nature to explore decentralized science further today at 3 pm CET.

Insights:

Breaking Tradition: Could Synthetic Biology Shape the Future of Winemaking? The wine industry is well known for its strong heritage, but climate change and evolving tastes might just coax in a new era of synbio wine.

Industry News:

• 3D Printed Biosensors Inspired by Spiderwebs Could Provide Advanced Virus Detection. Researchers are harnessing the unique properties of spiderwebs in pursuit of a droplet-based pathogen detection system.

• VitaDAO's Digital Democracy: Greenlighting Their First Biotech Venture. Through a unanimous community vote, VitaDAO announces its first venture into biotech with the introduction of Matrix Biosciences.

• Unraveling Psychedelics' Role in OCD. With 30% of psychedelic users reporting long-term relief from OCD symptoms, science is eager to explore this untapped potential.

Other news:

• The European Commission identified synthetic biology as a top technology shaping economic security and geopolitical competition (European Commission Website)

• How gene editing could help curb the spread of bird flu: The disease kills millions of birds yearly and has recently started to spread among mammals, too. (MIT Tech Review)

• Biomaterials Firm Bolt Threads, Formerly A Unicorn, Plans SPAC Deal At A $250 Million Valuation. CEO Dan Widmaier talks exclusively with Forbes about going public and the ups and downs of running a synthetic biology firm. (Forbes)

• Evonetix places first DNA synthesis development platform at Imperial College London: External placement marks a key milestone in developing Evonetix’s benchtop DNA synthesis technology in preparation for customer use and commercialization. (Cambridge Network)

• UK Government Seeks to Accelerate Approval of Cultivated Meat to Boost Food Security and Sustainability. (Vegconomist) 

Regards,

John

---

John Cumbers

CEO, SynBioBeta

Who's hiring?

• Research Associate, Molecular Biology & Strain Improvement at Checkerspot (Alameda, CA)

• Bioprocess Scientist at Peptobiotics (Singapore)